中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2014年
28期
70-72
,共3页
宫颈肿瘤%前调强放疗%常规放疗%疗效
宮頸腫瘤%前調彊放療%常規放療%療效
궁경종류%전조강방료%상규방료%료효
Cervix neoplasm%Intensity modulated radiation therapy in early stage%Conventional radiotherapy%Curative effect
目的:比较宫颈癌前期调强放疗与常规体外照射疗效。方法选择2009年9月-2010年9月在临沂市肿瘤医院初治宫颈癌患者80例的临床资料进行回顾性分析。结果前期调强组总生存率(66.8%)明显高于常规放疗组(30.4%)(P=0049)》常规放疗局部肿瘤消退时间(6.86±1.74)明显低于前期调强组(4.19±1.54)(P<0.01)》前期调强组急性膀胱直肠反映发生率明显低于常规组(P<0.05)》阴道狭窄骨髓抑制﹑晚期放疗反应均差异无统计学意义(P>0.05)。结论前期调强放疗可提高初治宫颈癌患者近期生存率及局部肿瘤控制率,并能减轻患者的部分急性放射性损伤。
目的:比較宮頸癌前期調彊放療與常規體外照射療效。方法選擇2009年9月-2010年9月在臨沂市腫瘤醫院初治宮頸癌患者80例的臨床資料進行迴顧性分析。結果前期調彊組總生存率(66.8%)明顯高于常規放療組(30.4%)(P=0049)》常規放療跼部腫瘤消退時間(6.86±1.74)明顯低于前期調彊組(4.19±1.54)(P<0.01)》前期調彊組急性膀胱直腸反映髮生率明顯低于常規組(P<0.05)》陰道狹窄骨髓抑製﹑晚期放療反應均差異無統計學意義(P>0.05)。結論前期調彊放療可提高初治宮頸癌患者近期生存率及跼部腫瘤控製率,併能減輕患者的部分急性放射性損傷。
목적:비교궁경암전기조강방료여상규체외조사료효。방법선택2009년9월-2010년9월재림기시종류의원초치궁경암환자80례적림상자료진행회고성분석。결과전기조강조총생존솔(66.8%)명현고우상규방료조(30.4%)(P=0049)》상규방료국부종류소퇴시간(6.86±1.74)명현저우전기조강조(4.19±1.54)(P<0.01)》전기조강조급성방광직장반영발생솔명현저우상규조(P<0.05)》음도협착골수억제﹑만기방료반응균차이무통계학의의(P>0.05)。결론전기조강방료가제고초치궁경암환자근기생존솔급국부종류공제솔,병능감경환자적부분급성방사성손상。
Objective To compare the effects between IMRT and conventional external radiation therapy on early cervical cancer. Methods The clinical data of 80 cases with cervical cancer initially treated in Linyi Tumor Hospital from September 2009 to September 2010 were selected and analyzed retrospectively. Results The overall survival rate (66.8%) of the group intervened by IMRT in early stage (IMRT group) was significantly higher than that(30.4%) of the conventional radiotherapy group (P=0049); the local tumor regression time of the conventional radiotherapy group (6.86 ± 1.74) was obviously shorter than that of the IMRT group (4.19 ± 1.54) (P<001); the incidence of acute bladder rectum reaction of the IMRT group was obviously lower than that of the nor-mal group (P<0.05); bone marrow suppression of vaginal stenosis, late radiation reactions were not statistically significant (P>0.05). Conclusion Intensity modulated radiation therapy in early stage can improve the short-term survival rate and local tumor control rate of the patients with cervical cancer treated initially, and alleviate part of the acute radiation injury of the patients.